戴裕光教授学术思想及治疗类风湿关节炎的经验研究
|
摘要
导师戴裕光教授从医40余年,中医经典理论功底深厚,临证经验丰富,擅长内科杂病、妇科、风湿病等的中医及中西医结合治疗,在治疗活动期类风湿关节炎患者证属风湿热郁型时善用当归拈痛汤加减以治之,临床效果较显著。本课题总结戴裕光教授学术思想及治疗类风湿关节炎的经验,并分别从临床与基础两方面,对加减当归拈痛汤治疗类风湿关节炎活动期的临床疗效进行了观察,并对该方的抗炎免疫作用及治疗类风湿关节炎的作用机制进行了研究。
本文以中医专家经验分析软件,对导师的经验和临证处方进行了研究;通过文献检索、归纳分析,总结历代文献对类风湿关节炎的认识;临床研究导师经验方加减当归拈痛汤治疗选取湿热痹阻型类风湿关节炎的疗效。湿热痹阻型类风湿关节炎患者76例,分组对照研究,在治疗前及治疗后评价压痛关节数、肿胀关节数、ESR、患者对疾病活动性总体VAS评价、疾病活动性评分DAS28、美国风湿病学会改善标准ACR20、ACR50、ACR70的达标比例及不良反应;实验研究以佐剂性关节炎大鼠为研究模型,通过药理、病理、细胞增殖、ELISA等方法,从整体、细胞及分子水平,观察加减当归拈痛汤的抗炎作用及其作用机制。
导师经验方分析显示,从性味归类来研究,导师用药喜寒温并用,注重阴阳之间的平衡,且偏好辛开、苦降、甘缓之味,以调畅脏腑气机。药物的归经分析显示多数药物直入病变所在之脏腑经脉。文献分析显示历代文献对关节肿胀已有较深入的论述,其病因多斥之于湿邪为患,与君火有余、脾土失运相关,其病机多为水湿流注关节、阳气郁结、湿痰凝滞、瘀血阻络。湿邪常与风、寒、热等邪气相合,临证之时,抓住“湿”这一导致关节肿胀的要素是施治的关键。关节肿胀的治疗原则不外祛湿利水、行气通阳、化痰活血,对与水湿相合之风、寒、热等邪气则针对性地采取疏风、散寒、泻热等治则。
临床研究提示两组患者晨僵时间、压痛关节数、肿胀关节数、ESR、疾病总体状况VAS评分、DAS28各项指标在治疗后均有明显改善(P＜0.05),两组间对照发现实验组的各项指标改善程度明显优于对照组(P＜0.05)。实验组中达到ACR20、ACR50、ACR70的比例明显高于对照组。两组患者的不良反应发生率均小,组间比较比较无显著性差异;
实验研究提示加减当归拈痛汤具有明显的抗炎作用,可显著降低佐剂性关节炎大鼠足爪肿胀程度和关节炎指数评分,减轻滑膜炎性细胞浸润、滑膜增生、血管翳形成,防止软骨损伤及骨的破坏;可抑制佛波醇乙酯(PhorbolMyristate Acetate,PMA)诱导的大鼠脾淋巴细胞增殖;可降低佐剂性关节炎大鼠血清TNF-α、IL-1等炎症细胞因子水平。
本文总结了戴裕光教授的学术思想、分析了其临证处方。导师经验方加减当归拈痛汤能显著改善类风湿关节炎的各项活动性指标,控制类风湿关节炎患者的急性期病情活动,无明显不良反应发生。加减当归拈痛汤可抑制淋巴细胞增殖,下调TNF-α、IL-1等炎症细胞因子的表达,具有明显的抗炎作用,这可能是加减当归拈痛汤治疗RA机制之一。
My doctoral supervisor,professor Dai Yuguang has been engaging in doctor for more than forty years.He has a solid foundation in Chinese Traditional Medicine,and a great deal of experience in clinical.Rheumatoid arthritis(RA) is a chronic systemic autoimmunity disease which threatened human's health. Jiajiandangguiniantong Tang had a good effect to treat RA.Professor Dai Yu-guang is experienced in treating RA with Jiajiandangguiniantong Tang in its acute stage of combination of wind,dampness and pyretic stagnation pattern.This research carries on a study on anti-inflmmation,immunity and treatment mechanism to RA of Jiajiandangguiniantong Tang.
To study the experience and prescription of professor Dai by analyzing the frequency of drugs,the class of efficacy,the property and flavor,the meridian distribution,and the dosage of drugs.We summarize the cognition of rheumatoid arthritis in TCM through literature retrieval and induction.
76 RA patients were divided into 2 groups,including 12 males and 64 females,who were diagnosed as moist heat arthralgia spasm syndrome during march 2006 to march 2008.The average age was 46.6±5.3,and average course was 5.3±6.7 years.The control group was taken methotrexate(MTX) plus leflunomide,while experimental group was treated with therapeutic alliance of MTX,leflunomide and Jiajiandangguiniantong Tang.The course of treatment was 12 weeks.The effect was evaluated by number of tenderness joints,number of swelling joints,ESR,Visual analogue scale of global disease activity estimated by the patient(VAS),Disease Activity Score in 28 joints(DAS28),recover rate whether reaches standard of American College of Rheumatology 20%,50%,70% improvement criteria(ACR20,ACR50,ACR70),and adverse effect after treatment finished.
Took adjuvant-induced arthritis rat as experimental model,treat with Jiajiandangguiniantong Tang,observed the anti-inflmmation,and treatment mechanism of Jiajiandangguiniantong Tang from the view of pharmacology, pathology,cell multiplication,ELISA.
The study showed that the two groups all produce a remarkable effective in early morning stiffness,number of tenderness joints,number of swelling joints, ESR,VAS score(by patient),DAS28(P＜0.05).The recover rate was much higher in experimental group than in control group.(P＜0.05).The incidence of adverse effect was quite low in each group,and had no significant difference.2). Jiajiandangguiniantong Tang has obviously effect of anti-inflammation,inhibition swelling of joints,reduce the arthritis index score,perimeter of ankle and thickness of calw.It can also lighten the synovial inflammation and the lesion of joints distinctly,and prevent the joint cartilage and bone from destruction. PMA-induced spleen lymphocytes proliferation in rat and the serum level of IL-1 and TNF-αin adjuvant-indued arthritis rat could also be inhibitied by Jiajiandangguiniantong Tang.
We summarized the learning thought and clinical experience of professor Dai Yuguang.Jiajiandangguiniantong Tang could significantly improve reactiveness indexes of RA,lessen pathogenetic condition,with no adverse effect.This decoction can inhibit spleen lymphocytes proliferation,decrease the serum level of IL-1 and TNF-αin adjuvant-indued arthritis rat,which may be one of the therapeutic mechanisms of Jiajiandangguiniantong Tang on RA.
本文以中医专家经验分析软件,对导师的经验和临证处方进行了研究;通过文献检索、归纳分析,总结历代文献对类风湿关节炎的认识;临床研究导师经验方加减当归拈痛汤治疗选取湿热痹阻型类风湿关节炎的疗效。湿热痹阻型类风湿关节炎患者76例,分组对照研究,在治疗前及治疗后评价压痛关节数、肿胀关节数、ESR、患者对疾病活动性总体VAS评价、疾病活动性评分DAS28、美国风湿病学会改善标准ACR20、ACR50、ACR70的达标比例及不良反应;实验研究以佐剂性关节炎大鼠为研究模型,通过药理、病理、细胞增殖、ELISA等方法,从整体、细胞及分子水平,观察加减当归拈痛汤的抗炎作用及其作用机制。
导师经验方分析显示,从性味归类来研究,导师用药喜寒温并用,注重阴阳之间的平衡,且偏好辛开、苦降、甘缓之味,以调畅脏腑气机。药物的归经分析显示多数药物直入病变所在之脏腑经脉。文献分析显示历代文献对关节肿胀已有较深入的论述,其病因多斥之于湿邪为患,与君火有余、脾土失运相关,其病机多为水湿流注关节、阳气郁结、湿痰凝滞、瘀血阻络。湿邪常与风、寒、热等邪气相合,临证之时,抓住“湿”这一导致关节肿胀的要素是施治的关键。关节肿胀的治疗原则不外祛湿利水、行气通阳、化痰活血,对与水湿相合之风、寒、热等邪气则针对性地采取疏风、散寒、泻热等治则。
临床研究提示两组患者晨僵时间、压痛关节数、肿胀关节数、ESR、疾病总体状况VAS评分、DAS28各项指标在治疗后均有明显改善(P＜0.05),两组间对照发现实验组的各项指标改善程度明显优于对照组(P＜0.05)。实验组中达到ACR20、ACR50、ACR70的比例明显高于对照组。两组患者的不良反应发生率均小,组间比较比较无显著性差异;
实验研究提示加减当归拈痛汤具有明显的抗炎作用,可显著降低佐剂性关节炎大鼠足爪肿胀程度和关节炎指数评分,减轻滑膜炎性细胞浸润、滑膜增生、血管翳形成,防止软骨损伤及骨的破坏;可抑制佛波醇乙酯(PhorbolMyristate Acetate,PMA)诱导的大鼠脾淋巴细胞增殖;可降低佐剂性关节炎大鼠血清TNF-α、IL-1等炎症细胞因子水平。
本文总结了戴裕光教授的学术思想、分析了其临证处方。导师经验方加减当归拈痛汤能显著改善类风湿关节炎的各项活动性指标,控制类风湿关节炎患者的急性期病情活动,无明显不良反应发生。加减当归拈痛汤可抑制淋巴细胞增殖,下调TNF-α、IL-1等炎症细胞因子的表达,具有明显的抗炎作用,这可能是加减当归拈痛汤治疗RA机制之一。
My doctoral supervisor,professor Dai Yuguang has been engaging in doctor for more than forty years.He has a solid foundation in Chinese Traditional Medicine,and a great deal of experience in clinical.Rheumatoid arthritis(RA) is a chronic systemic autoimmunity disease which threatened human's health. Jiajiandangguiniantong Tang had a good effect to treat RA.Professor Dai Yu-guang is experienced in treating RA with Jiajiandangguiniantong Tang in its acute stage of combination of wind,dampness and pyretic stagnation pattern.This research carries on a study on anti-inflmmation,immunity and treatment mechanism to RA of Jiajiandangguiniantong Tang.
To study the experience and prescription of professor Dai by analyzing the frequency of drugs,the class of efficacy,the property and flavor,the meridian distribution,and the dosage of drugs.We summarize the cognition of rheumatoid arthritis in TCM through literature retrieval and induction.
76 RA patients were divided into 2 groups,including 12 males and 64 females,who were diagnosed as moist heat arthralgia spasm syndrome during march 2006 to march 2008.The average age was 46.6±5.3,and average course was 5.3±6.7 years.The control group was taken methotrexate(MTX) plus leflunomide,while experimental group was treated with therapeutic alliance of MTX,leflunomide and Jiajiandangguiniantong Tang.The course of treatment was 12 weeks.The effect was evaluated by number of tenderness joints,number of swelling joints,ESR,Visual analogue scale of global disease activity estimated by the patient(VAS),Disease Activity Score in 28 joints(DAS28),recover rate whether reaches standard of American College of Rheumatology 20%,50%,70% improvement criteria(ACR20,ACR50,ACR70),and adverse effect after treatment finished.
Took adjuvant-induced arthritis rat as experimental model,treat with Jiajiandangguiniantong Tang,observed the anti-inflmmation,and treatment mechanism of Jiajiandangguiniantong Tang from the view of pharmacology, pathology,cell multiplication,ELISA.
The study showed that the two groups all produce a remarkable effective in early morning stiffness,number of tenderness joints,number of swelling joints, ESR,VAS score(by patient),DAS28(P＜0.05).The recover rate was much higher in experimental group than in control group.(P＜0.05).The incidence of adverse effect was quite low in each group,and had no significant difference.2). Jiajiandangguiniantong Tang has obviously effect of anti-inflammation,inhibition swelling of joints,reduce the arthritis index score,perimeter of ankle and thickness of calw.It can also lighten the synovial inflammation and the lesion of joints distinctly,and prevent the joint cartilage and bone from destruction. PMA-induced spleen lymphocytes proliferation in rat and the serum level of IL-1 and TNF-αin adjuvant-indued arthritis rat could also be inhibitied by Jiajiandangguiniantong Tang.
We summarized the learning thought and clinical experience of professor Dai Yuguang.Jiajiandangguiniantong Tang could significantly improve reactiveness indexes of RA,lessen pathogenetic condition,with no adverse effect.This decoction can inhibit spleen lymphocytes proliferation,decrease the serum level of IL-1 and TNF-αin adjuvant-indued arthritis rat,which may be one of the therapeutic mechanisms of Jiajiandangguiniantong Tang on RA.
引文
1 戴裕光.痹证论治 寒湿湿热.实用中医药杂志,2003,19:41-41.
2 王伟,史天慧.当归拈痛汤治疗类风湿性关节炎的实验研究.黑龙江中医药,2000:6-7.
3 袁立霞.当归拈痛汤治疗类风湿关节炎53例疗效观察.山东中医药大学学报,2008,32:407-408.
4 中医内科病证诊断疗效标准(十六).湖北中医杂志.2003,25:F003-F003.
5 类风湿关节炎诊治指南(草案).中华风湿病学杂志,2003,7:250-254.
6 袁立霞.当归拈痛汤及拆方对类风湿性关节炎大鼠血清IL—1β和TNF-α的影响.中华中医药学刊,2008,26:1213-1214.
7 刘刚[1],袁立霞[2].当归拈痛汤及其拆方对佐剂性关节炎大鼠滑膜组织Fas/FasLmRNA表达的影响.中医药信息,2008,25:32-34.
8 王敬翔,张艳华.当归拈痛汤治疗湿热痹50例.黑龙江中医药,2005:23-23.
9 佟丽,Kamal,D,等.南蛇藤提取物对Lewis大鼠佐剂性关节炎(AA)预防及治疗作用.中国免疫学杂志,2008,24:421-423.
10 Larsson P,Kleinau S,Holmdahl R,et al.Homologous type Ⅱcollagen-induced arthritis in rats.Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation.Arthritis Rheum,1990,33:693-701.
11 张乃峥.中国风湿病学的建立与发展.中华内科杂志,1992,31:498-501.
12 蒋明.加强类风湿关节炎的临床研究.中华医学杂志,1998,78:165-166.
13 唐福林.加强对类风湿关节炎早期诊断的实验室研究.中华风湿病学杂志,1998,2:1-2.
14 王一涛,杨奎,王家葵,等.羌活的药理学研究.中药药理与临床,1996,12:12-15.
15 董岩,王新芳,崔长军,等.茵陈蒿的化学成分和药理作用研究进展.时珍国医国药,2008,19:874-876.
16 田代华.实用中药辞典.北京:人民卫生出版社,2002.1279.
17 钱信忠.中国本草彩色图鉴.常用中药篇(上卷).北京:人民卫生出版社,1995.166-254.
18 董丽萍.葛根对免疫机制的作用.中国药理学报,1998,19:339.
19 延卫东,王瑞君,等.黄芩苷药理作用研究进展.陕西中医,2002,23:1127-1129.
20 骆和生,罗鼎辉.免疫中药学.北京:北京医科大学、中国协和医科大学联合出版社,1999.281.
21 Trentham DE,Townes AS,Kang AH.Autoimmunity to type Ⅱ collagen an experimental model of arthritis.J Exp Med,1977,146:857-68.
22 van Eden W,Thole JE,van der Zee R,et al.Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis.Nature,1988,331:171-3.
23 Marrack P,Kappler J,Kotzin BL.Autoimmune disease:why and where it occurs.Nat Med,2001,7:899-905.
24 Weyand CM.New insights into the pathogenesis of rheumatoid arthritis.Rheumatology(Oxford),2000,39 Suppl 1:3-8.
25 时步卿.类风湿性关节炎患者血清TNF-α和外周血B细胞及T细胞亚群的探讨.放射免疫学杂志,2006,19:197-199.
26 冷建杭,胡智勇,卓广超,等.类风湿关节炎患者外周血B淋巴细胞共刺激分子的表达及其意义.中华内科杂志,2004,43:519-521.
27 Zhang Z,Bridges SL Jr.Pathogenesis of rheumatoid arthritis.Role of B lymphocytes.Rheum Dis Clin North Am,2001,27:335-53.
28 Foxwell BM,Bondeson J,Brennan F,et al.Adenoviral transgene delivery provides an approach to identifying important molecular processes in inflammation:evidence for heterogenecity in the requirement for NFkappaB in tumour necrosis factor production.Ann Rheum Dis,2000,59 Suppl 1:i54-9.
[1]吕爱平,陈可冀.疾病的证候分类研究思路.中国中西医结合杂志.2005,25(9):843-845.
[2]焦树德.痹的辨证论治.中医杂志,1992,33(3):11.
[3]朱良春.痹证论治.中国中医药,2003,5:26-29.
[4]娄多峰.痹证治验.郑州:河南省科学技术出版社,1983,2-4.
[5]娄玉钤,娄玉州,娄多峰.浅谈痹病的分类.中医正骨,2000,12(9):21-23.
[6]陈小永,钱先.仲景辨治类风湿性关节炎学术思想初探.辽宁中医学院报,2004,6(6):486.
[7]王义军,胡荫奇.类风湿性关节炎证候规范化研究的思路与方法.中医药刊,2005,23(1):153.
[8]陈龙全,陈斌.类风湿关节炎的病因病机及其辨证分型.中医药学刊,2003,3(12):6.
[9]王炎焱,论中医药治疗类风湿关节炎的研究思路.中华医学丛 刊,2003,3(12):6.
[10]杨德华,钱玉中,姚筱,等.张国恩教授中晚期类风湿性关节炎治验浅析.中华实用中西医杂志,2004,4(17):1115-1116.
[11]汪红,周学平,王志英,等.除痹方治疗中晚期类风湿性关节炎的临床观察.山东中医药大学学报,2000,24(2):107-110.
[12]路志正,焦树德.实用中医风湿病学.北京:人民卫生出版社,2001:459-460.
[13]刘孟渊.类风湿性关节炎的证治体会.中医杂志,2001,42(8):465-467.
[14]雷裕后.分期辨治类风湿性关节炎32例.实用中医药杂志 2004,20(3):127.
[15]于秀明,刘学明.类风湿关节炎中医证候学研究.吉林中医药,2006,26(4):16-17.
[16]于秀明,刘学明,侯云峰,等.类风湿性关节炎中医辨证分型与实验室指标的研究.中华中医药学刊,2007,25(7):1462-1464.
[17]吕军影,黄李平,阙铁生,等.类风湿性关节炎辨证分型与临床指标关系研究.实用中医内科杂志,2007,21(9):38-39.
[18]姜泉,蒋红,曹炜,等.475例类风湿关节炎患者中医临床证候分析.中医杂志.2007;48(3):253-255.
[19]查青林,何羿婷,闫小萍,等.类风性关节炎主观症状因子分析及其与免疫指标的关系.中国中医基础医学杂志,2005,11(11):839-841.
[20]赵林华,闫小萍,汪建明,等.类风湿性关节炎的病理生理特点与中医四诊信息的相关性分析.广州中医药大学学报,2006,23(2):112-117.
[21]赵林华,肖诚,闫小萍,等.早期类风湿关节炎寒热证候分类与细胞因子及有关临床指标的相关性研究.上海中医药大学学报,2006,20(1):21-24.
[22]黄李平,吕军影,何源浩,等.类风湿性关节炎中医证型与免疫指标变化关系探讨.实用中西医结合临床,2002,2(3):3-4.
[23]何羿婷,付丽媛,阎小萍,等.类风湿性关节炎中医证候分布规律的初步探讨.中国 中医基础医学杂志,2004,10(1):26-28.
[24]邓兆智等.计算机模式识别法在类风湿性关节炎中医辨证型微量元素谱上的应用.广州中医学院学报.1992,9(4):216.
[25]邓兆智,何羿婷,余煜棉.计算机模式识别法在类风湿性关节炎中医证候诊断与常规临床判断的比较.中国中西医结合杂志.1996(12),727.
[26]邓兆智,文旺秀,余煜棉.不同证型类风湿性关节炎患者发样微量元素水平及其相关分析.中医杂志.1994,35(12):743.
[27]查青林,何羿婷,喻建平,等.基于决策树分析方法探索类风湿性关节炎证病信息与疗效的相关关系.中国中西医结合杂志 2006,26(10):871-876.
[28]查青林,何羿婷,卢毓雄,等.血小板数量与中西医治疗类风湿性关节炎疗效关系的探讨.中国中西医结合杂志.2007,27(1):29-2.
[29]查青林,何羿婷,闫小萍,等.基于神经网络分析方法探索类风湿关节炎证病信息对疗效的预测作用.中西医结合学报 2007,5(1):32-38.
[30]吕爱平.重视类风湿关节炎治疗的中医证候分类研究.中国中西医结合杂志.2007;27(7):587-588.
[31]吕诚,赵林华,肖诚,等.类风湿性关节炎患者外周血CD_4~+T淋巴细胞基因表达谱研究探讨.中华风湿病学杂志.2006;10(7):438-439.
[32]吕诚,肖诚,赵林华,等.寒热证候类风湿性关节炎患者外周血CD_4~+T淋巴细胞基因表达谱仞步探索.中国中医基础医学杂志.2006;12(2):130-133.
[33]查青林,何羿婷,闫小萍,等.从主观症状因子分析的结果看中医辨证的数学逻辑.江西中医学院学报.2005;17(1):79-81.
[34]肖诚,吕诚,赵林华,等.活动期和稳定期类风湿性关节炎寒热证候患者外周血CD_4~+T淋巴细胞基因表达谱探索.中国中医药信息杂志.2006;13(3):14-16.
[35]肖诚,赵林华,吕诚,等.类风湿关节炎类风湿因子阴性和阳性寒热证候患者外周血CD_4~+T细胞基因差异表达研究.中国中西医结合杂志,2006,26(8):689-693.
[26]黄闰月,黄清春,沈鹰.基质金属蛋白酶3与类风湿性关节炎中医证型相关 性的理论探讨.中医杂志,2007,48(10):872-873.
[37]胡祖光,洪介民,高敏,等.类风湿性关节炎2种不同证型与3种可溶性细胞因子受体之间的关系的探讨.中国中西医结合杂志,1999,19(12):720.
[38]胡祖光.类风湿性关节炎四种证型与sIL-2R及其他指标关系的探讨及消风痛的疗效.中药药理与临床,1997,13(5):41-44.
[39]吕爱平,王安民,曾晓莲,等.益肾蠲痹丸对大鼠实验性痹证的病理学研究.中医杂志,1988,(6):493.
[40]吕爱平,刘振丽,张枢明,等.宣发膜原法治疗小鼠免疫性关节炎机理的实验研究.中国中西医结合杂志,1997,17:679.
[41]Li S,Lv AP,Jia HW.Formulae with Cold and Heat Properties and Their Effects on Ultrastructures of Synoviocytes in Rats of the Collagen-Induced Arthritis.Journal of Traditional Chinese Medicine.2002;22(4):296-302.
[42]Zhang GG,Lee WL,Lao L,et al.The variability of TCM pattern diagnosis and herbal prescription on rheumatoid arthritis patients.Altern Ther Health Med.2004,10(1):58-63.
2 王伟,史天慧.当归拈痛汤治疗类风湿性关节炎的实验研究.黑龙江中医药,2000:6-7.
3 袁立霞.当归拈痛汤治疗类风湿关节炎53例疗效观察.山东中医药大学学报,2008,32:407-408.
4 中医内科病证诊断疗效标准(十六).湖北中医杂志.2003,25:F003-F003.
5 类风湿关节炎诊治指南(草案).中华风湿病学杂志,2003,7:250-254.
6 袁立霞.当归拈痛汤及拆方对类风湿性关节炎大鼠血清IL—1β和TNF-α的影响.中华中医药学刊,2008,26:1213-1214.
7 刘刚[1],袁立霞[2].当归拈痛汤及其拆方对佐剂性关节炎大鼠滑膜组织Fas/FasLmRNA表达的影响.中医药信息,2008,25:32-34.
8 王敬翔,张艳华.当归拈痛汤治疗湿热痹50例.黑龙江中医药,2005:23-23.
9 佟丽,Kamal,D,等.南蛇藤提取物对Lewis大鼠佐剂性关节炎(AA)预防及治疗作用.中国免疫学杂志,2008,24:421-423.
10 Larsson P,Kleinau S,Holmdahl R,et al.Homologous type Ⅱcollagen-induced arthritis in rats.Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation.Arthritis Rheum,1990,33:693-701.
11 张乃峥.中国风湿病学的建立与发展.中华内科杂志,1992,31:498-501.
12 蒋明.加强类风湿关节炎的临床研究.中华医学杂志,1998,78:165-166.
13 唐福林.加强对类风湿关节炎早期诊断的实验室研究.中华风湿病学杂志,1998,2:1-2.
14 王一涛,杨奎,王家葵,等.羌活的药理学研究.中药药理与临床,1996,12:12-15.
15 董岩,王新芳,崔长军,等.茵陈蒿的化学成分和药理作用研究进展.时珍国医国药,2008,19:874-876.
16 田代华.实用中药辞典.北京:人民卫生出版社,2002.1279.
17 钱信忠.中国本草彩色图鉴.常用中药篇(上卷).北京:人民卫生出版社,1995.166-254.
18 董丽萍.葛根对免疫机制的作用.中国药理学报,1998,19:339.
19 延卫东,王瑞君,等.黄芩苷药理作用研究进展.陕西中医,2002,23:1127-1129.
20 骆和生,罗鼎辉.免疫中药学.北京:北京医科大学、中国协和医科大学联合出版社,1999.281.
21 Trentham DE,Townes AS,Kang AH.Autoimmunity to type Ⅱ collagen an experimental model of arthritis.J Exp Med,1977,146:857-68.
22 van Eden W,Thole JE,van der Zee R,et al.Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis.Nature,1988,331:171-3.
23 Marrack P,Kappler J,Kotzin BL.Autoimmune disease:why and where it occurs.Nat Med,2001,7:899-905.
24 Weyand CM.New insights into the pathogenesis of rheumatoid arthritis.Rheumatology(Oxford),2000,39 Suppl 1:3-8.
25 时步卿.类风湿性关节炎患者血清TNF-α和外周血B细胞及T细胞亚群的探讨.放射免疫学杂志,2006,19:197-199.
26 冷建杭,胡智勇,卓广超,等.类风湿关节炎患者外周血B淋巴细胞共刺激分子的表达及其意义.中华内科杂志,2004,43:519-521.
27 Zhang Z,Bridges SL Jr.Pathogenesis of rheumatoid arthritis.Role of B lymphocytes.Rheum Dis Clin North Am,2001,27:335-53.
28 Foxwell BM,Bondeson J,Brennan F,et al.Adenoviral transgene delivery provides an approach to identifying important molecular processes in inflammation:evidence for heterogenecity in the requirement for NFkappaB in tumour necrosis factor production.Ann Rheum Dis,2000,59 Suppl 1:i54-9.
[1]吕爱平,陈可冀.疾病的证候分类研究思路.中国中西医结合杂志.2005,25(9):843-845.
[2]焦树德.痹的辨证论治.中医杂志,1992,33(3):11.
[3]朱良春.痹证论治.中国中医药,2003,5:26-29.
[4]娄多峰.痹证治验.郑州:河南省科学技术出版社,1983,2-4.
[5]娄玉钤,娄玉州,娄多峰.浅谈痹病的分类.中医正骨,2000,12(9):21-23.
[6]陈小永,钱先.仲景辨治类风湿性关节炎学术思想初探.辽宁中医学院报,2004,6(6):486.
[7]王义军,胡荫奇.类风湿性关节炎证候规范化研究的思路与方法.中医药刊,2005,23(1):153.
[8]陈龙全,陈斌.类风湿关节炎的病因病机及其辨证分型.中医药学刊,2003,3(12):6.
[9]王炎焱,论中医药治疗类风湿关节炎的研究思路.中华医学丛 刊,2003,3(12):6.
[10]杨德华,钱玉中,姚筱,等.张国恩教授中晚期类风湿性关节炎治验浅析.中华实用中西医杂志,2004,4(17):1115-1116.
[11]汪红,周学平,王志英,等.除痹方治疗中晚期类风湿性关节炎的临床观察.山东中医药大学学报,2000,24(2):107-110.
[12]路志正,焦树德.实用中医风湿病学.北京:人民卫生出版社,2001:459-460.
[13]刘孟渊.类风湿性关节炎的证治体会.中医杂志,2001,42(8):465-467.
[14]雷裕后.分期辨治类风湿性关节炎32例.实用中医药杂志 2004,20(3):127.
[15]于秀明,刘学明.类风湿关节炎中医证候学研究.吉林中医药,2006,26(4):16-17.
[16]于秀明,刘学明,侯云峰,等.类风湿性关节炎中医辨证分型与实验室指标的研究.中华中医药学刊,2007,25(7):1462-1464.
[17]吕军影,黄李平,阙铁生,等.类风湿性关节炎辨证分型与临床指标关系研究.实用中医内科杂志,2007,21(9):38-39.
[18]姜泉,蒋红,曹炜,等.475例类风湿关节炎患者中医临床证候分析.中医杂志.2007;48(3):253-255.
[19]查青林,何羿婷,闫小萍,等.类风性关节炎主观症状因子分析及其与免疫指标的关系.中国中医基础医学杂志,2005,11(11):839-841.
[20]赵林华,闫小萍,汪建明,等.类风湿性关节炎的病理生理特点与中医四诊信息的相关性分析.广州中医药大学学报,2006,23(2):112-117.
[21]赵林华,肖诚,闫小萍,等.早期类风湿关节炎寒热证候分类与细胞因子及有关临床指标的相关性研究.上海中医药大学学报,2006,20(1):21-24.
[22]黄李平,吕军影,何源浩,等.类风湿性关节炎中医证型与免疫指标变化关系探讨.实用中西医结合临床,2002,2(3):3-4.
[23]何羿婷,付丽媛,阎小萍,等.类风湿性关节炎中医证候分布规律的初步探讨.中国 中医基础医学杂志,2004,10(1):26-28.
[24]邓兆智等.计算机模式识别法在类风湿性关节炎中医辨证型微量元素谱上的应用.广州中医学院学报.1992,9(4):216.
[25]邓兆智,何羿婷,余煜棉.计算机模式识别法在类风湿性关节炎中医证候诊断与常规临床判断的比较.中国中西医结合杂志.1996(12),727.
[26]邓兆智,文旺秀,余煜棉.不同证型类风湿性关节炎患者发样微量元素水平及其相关分析.中医杂志.1994,35(12):743.
[27]查青林,何羿婷,喻建平,等.基于决策树分析方法探索类风湿性关节炎证病信息与疗效的相关关系.中国中西医结合杂志 2006,26(10):871-876.
[28]查青林,何羿婷,卢毓雄,等.血小板数量与中西医治疗类风湿性关节炎疗效关系的探讨.中国中西医结合杂志.2007,27(1):29-2.
[29]查青林,何羿婷,闫小萍,等.基于神经网络分析方法探索类风湿关节炎证病信息对疗效的预测作用.中西医结合学报 2007,5(1):32-38.
[30]吕爱平.重视类风湿关节炎治疗的中医证候分类研究.中国中西医结合杂志.2007;27(7):587-588.
[31]吕诚,赵林华,肖诚,等.类风湿性关节炎患者外周血CD_4~+T淋巴细胞基因表达谱研究探讨.中华风湿病学杂志.2006;10(7):438-439.
[32]吕诚,肖诚,赵林华,等.寒热证候类风湿性关节炎患者外周血CD_4~+T淋巴细胞基因表达谱仞步探索.中国中医基础医学杂志.2006;12(2):130-133.
[33]查青林,何羿婷,闫小萍,等.从主观症状因子分析的结果看中医辨证的数学逻辑.江西中医学院学报.2005;17(1):79-81.
[34]肖诚,吕诚,赵林华,等.活动期和稳定期类风湿性关节炎寒热证候患者外周血CD_4~+T淋巴细胞基因表达谱探索.中国中医药信息杂志.2006;13(3):14-16.
[35]肖诚,赵林华,吕诚,等.类风湿关节炎类风湿因子阴性和阳性寒热证候患者外周血CD_4~+T细胞基因差异表达研究.中国中西医结合杂志,2006,26(8):689-693.
[26]黄闰月,黄清春,沈鹰.基质金属蛋白酶3与类风湿性关节炎中医证型相关 性的理论探讨.中医杂志,2007,48(10):872-873.
[37]胡祖光,洪介民,高敏,等.类风湿性关节炎2种不同证型与3种可溶性细胞因子受体之间的关系的探讨.中国中西医结合杂志,1999,19(12):720.
[38]胡祖光.类风湿性关节炎四种证型与sIL-2R及其他指标关系的探讨及消风痛的疗效.中药药理与临床,1997,13(5):41-44.
[39]吕爱平,王安民,曾晓莲,等.益肾蠲痹丸对大鼠实验性痹证的病理学研究.中医杂志,1988,(6):493.
[40]吕爱平,刘振丽,张枢明,等.宣发膜原法治疗小鼠免疫性关节炎机理的实验研究.中国中西医结合杂志,1997,17:679.
[41]Li S,Lv AP,Jia HW.Formulae with Cold and Heat Properties and Their Effects on Ultrastructures of Synoviocytes in Rats of the Collagen-Induced Arthritis.Journal of Traditional Chinese Medicine.2002;22(4):296-302.
[42]Zhang GG,Lee WL,Lao L,et al.The variability of TCM pattern diagnosis and herbal prescription on rheumatoid arthritis patients.Altern Ther Health Med.2004,10(1):58-63.